Immunovia AB
(OSTO:IMMNOV)
kr
0.618
-0.01 (-1.59%)
Market Cap: 104.88 Mil
Enterprise Value: 76.83 Mil
PE Ratio: 0
PB Ratio: 2.91
GF Score: 44/100 Immunovia AB (publ)-Invitation to Immunovia's Presentation of PanFAM-1 Transcript
Jun 27, 2022 / 11:00AM GMT
Release Date Price:
kr15.17
(-23.49%)
Operator
Presentation of PanFAM-1
Jun 27, 2022 / 11:00AM GMT
=====================
Corporate Participants
=====================
* Jeff Borcherding
Immunovia AB (publ) - CEO of US, Immunovia, Inc.
* Philipp Mathieu
Immunovia AB (publ) - CEO & President
* Thomas C. King
Immunovia AB (publ) - Medical Director
* Tobias Bülow
Immunovia AB (publ) - Senior Director of IR & Corporate Communications
=====================
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot